CompletedNot Applicable

MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study (MAGUS)

Belgium16 participantsStarted 2020-02-19

Plain-language summary

A novel magnetic device, called MAgnetic Gastrointestinal Universal Septotome (MAGUS) was designed to improve the Treatment of diverticulum of the esophagus, Pseudo-diverticulum of the upper GI tract, Candy cane syndrome This study aims to evaluating the safety of the feasability of this new device.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diverticulum of the esophagus;
✓. A pseudo-diverticulum of the upper GI tract;
✓. Candy cane syndrome;

What they're measuring

Technical magnet placement success

Timeframe: Day 0

Type of evacuation of the device

Timeframe: During 28 Days post-placement

Incidence of all adverse event

Timeframe: During 30 days post-placement

Trial details

NCT IDNCT04480216

SponsorErasme University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-09-15

View on ClinicalTrials.gov More Diverticulum, Esophageal trials